We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...
Friday is the third and final day of initial hearings for the more than two dozen men who authorities say are among the most ...
"The government should step in to facilitate lower prices, as has occurred in the rest of the world," writes one reader.
Unique siRNA platform, developed with Nobel Prize Laureate Craig Mello, offers potential for treating multiple dermatology indications ALY-101 is formulated as an intradermal injectable for ...
Brighton Music Hall opened its doors to rising musical royalty, Spencer Sutherland, for the second time, backed by openers ...
For the Utah Jazz, they announced the Jordan Clarkson will be out tonight with Plantar Fasciitis. It looks like the Jazz will ...
The Utah Jazz are back to the grind on Tuesday night, facing off against the Memphis Grizzlies for their fifth of a six-game home stint.
Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line data anticipated in 2H 2026 4WARD trial protocol refined ...
Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.
X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $39.8 million in its fourth quarter. On a per-share basis, the Boston-based company said it had a loss of ...
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...
The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results